Page 2 - பராமரிப்பு நீண்டது கடற்கரை மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பராமரிப்பு நீண்டது கடற்கரை மருத்துவ மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பராமரிப்பு நீண்டது கடற்கரை மருத்துவ மையம் Today - Breaking & Trending Today

MemorialCare Heart & Vascular Institute at Long Beach Medical Center Welcomes Elvis Cami, M.D., as Medical Director of Advanced Cardiac Imaging


Share this article
Share this article
LONG BEACH, Calif., Feb. 19, 2021 /PRNewswire/  The MemorialCare Heart & Vascular Institute at Long Beach Medical Center is expanding its leadership team by naming Elvis Cami, M.D. as the first medical director of advanced cardiac imaging. Advanced cardiac imaging is transforming the way heart disease is diagnosed and treated, significantly improving patient outcomes. Dr. Cami brings extensive training in cardiac imaging technology and techniques to our community, ensuring that patients receive the most accurate and timely diagnosis and the most advanced and personalized treatments for heart disease.
Elvis Cami, M.D., Medical Director, Advanced Cardiac Imaging, MemorialCare Heart & Vascular Institute, Long Beach Medical Center ....

United States , Royal Oak , Beaumont Hospital , Ike Mmeje , Los Angeles Metro , Society Of Cardiac Imaging , Society Of Cardiac Computed Tomography , American College Of Cardiology , Long Beach Medical Center , Memorialcare Long Beach Medical Center , University Of Michigan Health System , Memorialcare Heart Vascular Institute , Oakland University William Beaumont School Of Medicine , University Of Toledo College Medicine , American Society Of Echocardiography , Oakland University William Beaumont School , Memorialcare Heart , Vascular Institute , Toledo College , Michigan Health , American Society , Cardiac Computed Tomography , Cardiac Imaging , American College , Long Beach Medical , Care Long Beach Medical Center ,

Long Beach Medical Center welcomes Elvis Cami, M.D., as Medical Director of Advanced Cardiac Imaging


The MemorialCare Heart & Vascular Institute at Long Beach Medical Center is expanding its leadership team by naming Elvis Cami, M.D. as the first medical director of advanced cardiac imaging. Advanced cardiac imaging is transforming the way heart disease is diagnosed and treated, significantly improving patient outcomes. Dr. Cami brings extensive training in cardiac imaging technology and techniques to our community, ensuring that patients receive the most accurate and timely diagnosis and the most advanced and personalized treatments for heart disease.
“Cardiac imaging allows us to diagnose heart disease with precision,” says Dr. Cami. “Not only are we able to precisely identify a patient’s cardiovascular condition using cardiac imaging methods and techniques like cardiac computerized tomography (CT), cardiac magnetic resonance imaging (MRI), echocardiography and intraoperative imaging, but we also use 3D imaging and 3D printing to provide the care team with a proced ....

United States , Royal Oak , Beaumont Hospital , Ike Mmeje , Elvis Cami , Los Angeles Metro , Society Of Cardiac Imaging , Society Of Cardiac Computed Tomography , American College Of Cardiology , Long Beach Medical Center , Memorialcare Long Beach Medical Center , University Of Michigan Health System , Memorialcare Heart Vascular Institute , Oakland University William Beaumont School Of Medicine , University Of Toledo College Medicine , American Society Of Echocardiography , Memorialcare Heart , Vascular Institute , Oakland University William Beaumont School , Toledo College , Michigan Health , American Society , Cardiac Computed Tomography , Cardiac Imaging , American College , Long Beach Medical ,

InCarda Therapeutics Announces Enrollment of First U.S. Patient in Phase 2 INSTANT Trial of InRhythm™ for Treatment of Atrial Fibrillation


Share:
SAN FRANCISCO, Jan. 19, 2021 (GLOBE NEWSWIRE) InCarda Therapeutics, Inc. ( InCarda ), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today announced dosing of the first U.S. patient in the company s multinational INSTANT Phase 2 clinical trial of InRhythm
™ (flecainide for inhalation) in patients with recent-onset paroxysmal atrial fibrillation (PAF). The trial is currently being conducted at centers in the U.S. and Europe to evaluate the optimal dose (120 mg) of InRhythm that was selected based on the positive results from the open-label, dose-ranging stage of the INSTANT study.
The results from the dose-ranging stage of the trial were recently presented at the American Heart Association s (AHA) Scientific Sessions 2020. InCarda Therapeutics in collaboration with clinical investigators reported that oral inhaled flecainide can safely and rapidly convert recent-onset PAF to normal si ....

United States , Coll Cardiol , Marky Lee , Luiz Belardinelli , Incarda Therapeutics Inc , American Heart Association , Memorialcare Long Beach Medical Center , Long Beach Medical Center , Incarda Therapeutics , Scientific Sessions , Memorialcare Long Beach Medical , Incarda Therapeutics , Care Long Beach Medical Center , Atrial Fibrillation , ஒன்றுபட்டது மாநிலங்களில் , மார்க்கி லீ , அமெரிக்கன் இதயம் சங்கம் , நீண்டது கடற்கரை மருத்துவ மையம் , அட்டை சிகிச்சை , அறிவியல் அமர்வுகள் , பராமரிப்பு நீண்டது கடற்கரை மருத்துவ மையம் , ஏட்ரியல் குறு நடுக்கம் ,